YESINTEK, is intended for the treatment of adults and children with plaque psoriasis and adults with psoriatic arthritis or Crohn's disease
WELIREG is the first and only oral hypoxia-inducible factor-2 alpha inhibitor approved in the European Union
This Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability
Glenmark’s Clindamycin Phosphate Foam, 1% is bioequivalent and therapeutically equivalent to Evoclin Foam, 1%, of Mylan Pharmaceuticals.
Total Income during Q3 FY25 stood at Rs. 527.37 crore as compared to Rs. 528.77 crore in Q3 FY24
He has over 23 years of experience across sectors
International Meeting of World Pharmacopoeias serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization
The company will showcase groundbreaking innovations from its Pharma and Nutrition divisions, highlighting key ingredients and formulations designed to support holistic well-being
Novel illumination system with key components molded in Radel® PPSU for durability and repeated sterilization
Torrent Pharmaceuticals has reported total income of Rs. 2,842 crores during the period ended December 31, 2024
Subscribe To Our Newsletter & Stay Updated
